# Diabetic pulmonary microangiopathy and its association with glycated haemoglobin and other diabetic complications

## TL;DR

This study shows that diabetes can affect lung function, with poor blood sugar control linked to worse lung health.

## Contribution

The study identifies a link between diabetic microangiopathy and lung function decline, independent of disease duration.

## Key findings

- Diabetics showed significantly reduced FVC, FEV1, and PEFR compared to controls.
- Poor glycemic control correlated strongly with reduced lung function.
- Lung function metrics correlated with albuminuria and retinopathy.

## Abstract

Diabetes mellitus is a systemic disease now recognized to affect the lungs through microangiopathy. This cross-sectional study
assessed pulmonary function via spirometry in 132 diabetics and 132 controls. Diabetics showed significantly reduced FVC, FEV1 and PEFR,
consistent with a restrictive pattern. Poor glycemic control correlated strongly with reduced lung function, while disease duration did
not. Spirometry findings also correlated with albuminuria and retinopathy, supporting early screening utility.